Volume 10 Supplement 1
2nd Cross Company Respiratory Symposium
Edited by Richard Knowles and Kathy H Abbott-Banner
The conference and publication of this supplement were supported by Pfizer. The organizing committee, which included a representative from Pfizer, was involved in selecting abstracts for oral and poster presentations at the meeting. RK is a scientific consultant on respiratory and inflammation models on drug discovery as well as CEO of an SME developing anti-inflammatory medicines. KAB has no competing interests.
2nd Cross Company Respiratory Symposium.
Horsham, UK6-7 September 2012
Affiliated with the British Inflammation Research Association (BIRAs).
Annual Journal Metrics
69 days to first decision for reviewed manuscripts only
53 days to first decision for all manuscripts
111 days from submission to acceptance
14 days from acceptance to publication
2.662 - 2-year Impact Factor
2.885 - 5-year Impact Factor
0.877 - Source Normalized Impact per Paper (SNIP)
1.015 - SCImago Journal Rank (SJR)
69 Altmetric mentions